These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2086822)

  • 1. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H; Yamao H; Saito H; Ohno R; Hotta T; Ohnishi K; Murate T; Kagami Y; Mitomo Y; Nitta M
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
    Kageyama T; Ohyabu H; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Yonezawa T
    Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
    Seriu T; Tsuda S; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H; Yokota S
    Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
    Urabe A; Takaku F; Mizoguchi H; Nomura T; Aoki N; Yamaguchi H; Mutoh Y; Miura Y; Toyama K; Hirashima K
    Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M; Hirashima K
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of severe infection in patients with hematological disorders by cefminox. Tokai Infection Study Group].
    Okumura M; Ohno R; Mitomo Y; Hirano M; Shirakawa S; Yoshikawa S; Kobayashi M; Yamada K
    Jpn J Antibiot; 1985 Jun; 38(6):1619-24. PubMed ID: 3930807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S; Tsuda S; Taniwaki M; Horiike S; Ariyama Y; Hirakawa K; Ueda Y; Kaneko H; Nakao M; Kashima K
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on effect of cefbuperazone on surgical infections].
    Kai H; Sugimachi K; Tamada R; Takenaka K; Inuzuka S; Natsuda Y; Taguchi J; Kobayashi M; Kaneko T; Mitarai Y
    Jpn J Antibiot; 1988 Mar; 41(3):322-30. PubMed ID: 3043033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M; Kobayashi Y; Endo K; Kawai N; Tominaga K; Bessho M; Hirashima K
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An evaluation of combination antibiotic therapy in infections with hematological disorders. Hyogo Cooperative Study Group of Infectious Diseases Complicating Hematological Disorders].
    Takemoto Y; Kanamaru A; Kakishita E; Nakayama S; Hara H; Yamaguchi N; Tsutsui T; Mitsutani S; Tago H; Sonoda T
    Jpn J Antibiot; 1991 Mar; 44(3):296-302. PubMed ID: 1880911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
    Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Nishigaki H; Yokota S
    Jpn J Antibiot; 1993 Aug; 46(8):686-96. PubMed ID: 8230736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
    Yamane T; Nakao Y; Yasui Y; Ota K; Ohira H; Inoue T; Furukawa Y; Hiyoshi M; Sasaki A; Kishida T
    Jpn J Antibiot; 1990 Nov; 43(11):1843-9. PubMed ID: 2287053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects of cefodizime in severe infections complicated with hematological diseases. Hanshin Infection Study Group].
    Teshima H; Masaoka T; Hiraoka A; Horiuchi A; Hasegawa H; Kitani T; Tagawa S; Yonezawa T; Kanayama Y; Take H
    Jpn J Antibiot; 1992 Oct; 45(10):1295-304. PubMed ID: 1479681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.